Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.67 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 4/20 | 0.50 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.50 |
| ▸ | DNM1 | Q05193 | 4/20 | 0.48 |
| ▸ | FDPS | P14324 | 1/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL9440008 | 1.00 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL19834901 | 1.00 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL1049935 | 1.00 | SLC22A1 (0.67) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28346602 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL29164921 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28547697 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28261378 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28973536 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28374654 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrabuthylammonium SCHEMBL1953259 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1016 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079810-A | Aromatic diamine and polyimide containing amido, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-4690281-A1 | COMPOSITION FOR TIN HARD MASK REMOVAL WHILE COMPATIBLE WITH TUNGSTEN | Versum Materials US, LLC (US) | 2026-02-11 | — | — | EP | claimed |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | ENTEGRIS INC (US) | 2026-01-15 | — | — | US | claimed |
| US-20250388596-A1 | PROCESS FOR THE EXTRACTION AND PURIFICATION OF TETRODOTOXIN | WEX PHARMACEUTICALS INC (CA) | 2025-12-25 | — | — | US | claimed |
| US-20250382711-A1 | METHOD OF PREPARING 2-HYDROXYADPIC ACID AND ADIPIC ACID | NATIONAL CHENG KUNG UNIVERSITY (TW) | 2025-12-18 | — | — | US | claimed |
| US-20250362278-A1 | MASS SPECTROMETRY OF MRNA | MODERNATX, INC. (US) | 2025-11-27 | — | — | US | claimed |
| EP-4565694-A1 | EXTRACTION-LESS REVERSE PHASE (RP) CHROMATOGRAPHY FOR MRNA PURITY ASSESSMENT | ModernaTX, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| CN-118773626-B | Method for preparing adiponitrile by electrolyzing acrylonitrile based on anode sacrificial agent | 重庆大学 | 2025-06-03 | — | — | CN | claimed |
| WO-2025111479-A1 | FLUOROGENIC SUBSTRATES AND METHODS OF USE | ABBOTT LABORATORIES (US) | 2025-05-30 | — | — | WO | claimed |
| WO-2025104679-A1 | PROCESSES FOR MAKING INTERMEDIATES FOR ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION HAVING ANTICANCER ACTIVITY | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2025-05-22 | — | — | WO | claimed |
| EP-2095188-A1 | HARDMASK COMPOSITION FOR PROCESSING RESIST UNDERLAYER FILM, PROCESS FOR PRODUCING SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE USING THE HARDMASK COMPOSITION, AND SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE PRODUCED BY THE PROCESS | Cheil Industries Inc. (KR) | 2009-09-02 | — | — | EP | claimed |
| WO-2009088177-A2 | SILICON-BASED HARDMASK COMPOSITION (SI-SOH; SI-BASED SPIN-ON HARDMASK) AND PROCESS OF PRODUCING SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE USING THE SAME | CHEIL INDUSTRIES INC. (KR) | 2009-07-16 | — | — | WO | claimed |
| WO-2009016269-A1 | WATER-SOLUBLE ETHYLIDENE PHOSPHATE PRODRUG OF PROPOFOL | OY FENNOPHARMA LTD (FI) | 2009-02-05 | — | — | WO | claimed |
| WO-2008063016-A1 | HARDMASK COMPOSITION FOR PROCESSING RESIST UNDERLAYER FILM, PROCESS FOR PRODUCING SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE USING THE HARDMASK COMPOSITION, AND SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE PRODUCED BY THE PROCESS | CHEIL INDUSTRIES INC. (KR) | 2008-05-29 | — | — | WO | claimed |
| US-20080118875-A1 | Hardmask composition and associated methods | CHEIL INDUSTRIES, INC. (KR) | 2008-05-22 | — | — | US | claimed |
| US-7355059-B2 | Preparation of sulfide chain-bearing organosilicon compounds | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2008-04-08 | — | — | US | claimed |
| US-20050196789-A1 | Preparation of biologically derived fluids for biomarker determination by mass spectrometry | APPLERA CORPORATION (US) | 2005-09-08 | — | — | US | claimed |
| US-6773822-B2 | ANTIFUNGAL AGENT MAY BE PRESENT IN THE GYPSUM CORE AND/OR ON ONE OR BOTH OF THE PAPER FACINGS, AND MAY BE ENCAPSULATED IN A MATERIAL THAT RELEASES THE ANTIFUNGAL AGENT OVER TIME AND/OR UPON EXPOSURE TO MOISTURE. | TEMPLE-INLAND FOREST PRODUCTS CORPORATION | 2004-08-10 | — | — | US | claimed |
| EP-0367447-A1 | Human epithelial transforming growth factor | SMITHKLINE BEECHAM CORPORATION (US) | 1990-05-09 | — | — | EP | claimed |
| US-4522729-A | CXONTACTING IMPORITIES WITH TETRAALKYLAMMONIUM SALT | PHILLIPS PETROLEUM COMPANY (US) | 1985-06-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | TET2, ASIC1, PIEZO1 | SLC22A1 2747/4885SLC22A2 2992/4885ALDH1A1 789/4885 |
| US-20250388596-A1 | PROCESS FOR THE EXTRACTION AND PURIFICATION OF TETRODOTOXIN | TRPA1, CACNA1D, SCN2A | SLC22A1 3782/4885SLC22A2 3591/4885ALDH1A1 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.